Nitric oxide synthesis and L-arginine in uremia

Mineral and Electrolyte Metabolism

Volumn 23, Issue 3-6, 1997, Pages 151-156

  Aiello, Sistiana ^a   Noris, Marina ^a   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Chronic renal failure; L Arginine; Nitric oxide; Nitric oxide synthase

Indexed keywords

ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

CONFERENCE PAPER; HUMAN; NONHUMAN; PRIORITY JOURNAL; UREMIA;

ANIMALS; ARGININE; HUMANS; KIDNEY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UREMIA;

EID: 0030679627     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. Moncada S, Higgs EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995;9:1319-1330.
2. Furchgott RF, Zawadski JV: The obligatory role of endothelial cells in the relaxation of smooth muscle by acetylcholine. Nature 1980;288:373-376.
3. Palmer RMJ, Rees DD, Ashton DS, Moncada S: L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988;153:1251-1256.
4. Rees DD, Palmer RM, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989;86:3375-3378.
5. Moncada S, Higgs EA: The L-arginine-nitric oxide pathway. N Engl J Med 1993;239:2002-2012.
6. Broekman MJ, Eiroa AM, Marcus AJ: Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: Blockade of aggregation and secretion by aspirin-insensitive mechanism. Blood 1991;78:1033-1040.
7. Sneddon JM, Vane JR: Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 1988;85: 2800-2804.
8. Wang Y, Marsden PA: Nitric oxide synthases: Biochemical and molecular regulation. Curr Opin Nephrol Hypertens 1995;4:12-22.
9. Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S: Role of nitric oxide in renal medullary oxygenation: Studies in isolated and intact rat kidneys. J Clin Invest 1991;88:390-395.
10. Shultz PJ, Schorer AE, Raij L: Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am J Physiol 1990;258:F162-F167.
11. Biondi ML, Dousa T, Vanhoutte P, Romero JC: Evidence for the existence of endothelium-derived relaxing factor in the renal medulla. Am J Hypertens 1990;3:876-878.
12. Bachmann S, Mundel P: Nitric oxide in the kidney: Synthesis, localization and function. Am J Kidney Dis 1994;24:112-119.
13. Terada Y, Tomita K, Nonoguchi H, Mammo F: Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylyl cyclase messenger RNAs in microdissected rat nephron segments. J Clin Invest 1992;90:659-665.
14. Ujiie K, Yuen J, Hogarth L, Danziger R, Star RA: Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am J Physiol 1994;267:F296-F302.
15. Ito S: Nitric oxide in the kidney. Curr Opin Nephrol Hypertens 1995;4:23-30.
16. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992;90:278-281.
17. Imig JD, Roman RJ: Nitric oxide modulates vascular tone in preglomerular arterioles. Hypertension 1992;19:770-774.
18. Ito S, Ren Y: Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest 1993;92:1093-1098.
19. Pfeilschifter J, Kunz D, Muhl H: Nitric oxide: An inflammatory mediator of glomerular mesangial cells. Nephron 1993;64:518-525.
20. McLay JS, Chatterjee P, Nicolson AG, Jardine AG, MacKay NG, Ralston SH, Grabowski P: Nitric oxide production by human proximal tubular cells: A novel immunomodulatory mechanism? Kidney Int 1994;46:1043-1049.
21. Morrissey JJ, McCracken R, Kaneto H, Vehaskari M, Montani D, Klahr S: Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int 1994;45:998-1005.
22. McKee M, Scavone C, Nathanson JA: Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc Natl Acad Sci USA 1994;91:12056-12060.
23. +-ATPase by nitric oxide in mouse proximal tubule epithelial cells. J Clin Invest 1995;95:2083-2088.
24. Cook HT, Cattell V: Nitric oxide synthetic pathway and regulation: Its potential role in immune and inflammatory reactions in the glomerulus. J Nephrol 1995;8:247-254.
25. Anderson S, Meyer TW, Brenner BM: The role of hemodynamic factors in the initiation and progression of renal disease. J Urol 1985;133:310-315.
26. Remuzzi G, Perico N, Zoja C, Corna D, Macconi D, Viganò G: Role of endothelium-derived nitric oxide in the bleeding tendency of uremia. J Clin Invest 1990;86:1768-1771.
27. Reyes AA, Purkerson ML, Karl I, Klahr S: Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992;20:168-176.
28. Ashab I, Peer G, Blum M, Wollman Y, Chermibovsky T, Hassner A, Schwartz D: Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 1995;47:1515-1521.
29. Aiello S, Noris M, Corna D, Benigni A, Zoya C, Todeschini N, Remuzzi G: Defective renal synthesis of nitric oxide in rats with reduced renal mass (abstract). J Am Soc Nephrol 1994;5:936.
30. Zappella S, Noris M, Aiello S, Corna D, Benigni A, Zoya C, Remuzzi G: Renal and systemic nitric oxide synthase expression in rats with renal mass reduction. J Am Soc Nephrol 1996;abstract, 7: A3105.
31. Mitch W, Chesney R: Amino acid metabolism by the kidney. Miner Electrolyte Metab 1983;9:190-202.
32. Chan W, Wang M, Kopple J, Swendseid M: Citrulline levels and urea cycle enzymes in uremic rats. J Nutr 1974;104:678-683.
33. Boudy N, Hassler C, Parvy P, Bankir L: Renal synthesis of arginine in chronic renal failure: In vivo and in vitro studies in rats with 5/6 nephrectomy. Kidney Int 1993;44:676-683.
34. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, Johnson RJ: Glomerular cell proliferation and FDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992;41:297-309.
35. Lee LK, Meyer TW, Pollock AS, Lovett DH: Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 1995;96:953-964.
36. Ketteler M, Border WA, Noble NA: Cytokines and L-arginine in renal injury and repair. Am J Physiol 1994;267:F197-F207.
37. Beck KF, Mohaupt MG, Sterzel RB: Endothelin-1 inhibits cytokine-stimulated transcription of inducible nitric oxide synthase in glomerular, mesangial cells. Kidney Int 1995;48:1893-1899.
38. Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, Benatti L, Remuzzi G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 1993;43:354-358.
39. Garg U, Hassid A: Inhibition of rat mesangial mitogenesis by nitric oxide-generating vasodilators. Am J Physiol 1989;257:F60-F66.
40. Ingram A, Parbtani A, Thai K, Ly H, Shankland SJ, Morrissey G, Smoley JU: Dietary supplementation with L-arginine limits cell proliferation in the remnant glomerulus. Kidney Int 1995;48:1857-1865.
41. Corna D, Noris M, Luzzana E, Benigni A, Zoja C, Todeschini N, Remuzzi G: A nitric oxide-donor either as prophylaxis or therapy slows renal disease progression and prolongs survival in remnant kidney. J Am Soc Nephrol 1996;Abstract, 7:A3029.
42. Noris M, Morigi M, Donadelli R, Aiello S, Foppolo M, Todeschini N, Orisio S, Remuzzi G, Remuzzi A: Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 1995; 76:536-543.
43. Awolesi MA, Sessa WC, Sumpio BE: Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest 1995;96:1449-1454.
44. Noris M, Benigni A, Boccardo P, Aiello S, Gaspari F, Todeschini N, Figliuzzi M, Remuzzi G: Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension. Kidney Int 1993;44:445-450.
45. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Maynot A, Urger C, Dahmane D, de Groote D, Jungers P, Dayer JM: Balance between IL-1β, TNF-α and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol 1995;154:882-892.
46. Metcoff J, Pederson J, Gable J, Llach F: Protein synthesis, cellular amino acids, and energy levels in CAPD patients. Kidney Int 1987;32:S136-S144.
47. Jungers P, Chauveau P, Ceballos I, Bardet J, Parvy P, Hannedouche T, Kamoun P: Plasma free amino acid alterations from early to end-stage chronic renal failure. J Nephrol 1994;7:48-54.
48. Hogman M, Frostell C, Arnberg H, Hedenstierna G: Bleeding time prolongation and NO inhalation. Lancet 1993;341:1664-1665.
49. Remuzzi G: Bleeding in renal failure. Lancet 1988;1:1205-1208.